These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21130675)

  • 41. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Seroepidemiological study of HBV infection in Hunan area].
    Xiao YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Jun; 11(3):133-7. PubMed ID: 2390776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatitis B viral markers in Bushmen at Schmidtsdrift, South Africa: baseline studies for immunisation.
    Gaobepe M; Aspinall S; Bos P
    East Afr Med J; 1995 Jul; 72(7):421-3. PubMed ID: 7498022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
    Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
    Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Seroepidemiological study of hepatitis B virus infection in a university community].
    González G; Viamonte A; Pérez-Maldonado C
    G E N; 1994; 48(3):116-20. PubMed ID: 7768414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours.
    Alexopoulos CG; Vaslamatzis M; Hatzidimitriou G
    Br J Cancer; 1999 Sep; 81(1):69-74. PubMed ID: 10487614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
    Evans AA; O'Connell AP; Pugh JC; Mason WS; Shen FM; Chen GC; Lin WY; Dia A; M'Boup S; Dramé B; London WT
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):559-65. PubMed ID: 9681522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The detection of the markers of viral hepatitis B in medical personnel by a radioimmunological method].
    Marievskiĭ VF; Leĭbenzon AS
    Vrach Delo; 1990 Oct; (10):106-7. PubMed ID: 2080558
    [No Abstract]   [Full Text] [Related]  

  • 53. Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone.
    Wurie IM; Wurie AT; Gevao SM
    West Afr J Med; 2005; 24(1):18-20. PubMed ID: 15909704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of hepatitis B in a small urban sexually transmitted disease clinic.
    Morris BA; Harason P; Butler-Jones D
    Can J Public Health; 1992; 83(1):73-4. PubMed ID: 1571888
    [No Abstract]   [Full Text] [Related]  

  • 55. Seroprevalence of hepatitis B infection in Turkish children.
    Kuyucu N; Dökmen A; Yöney A; Teziç T
    Infection; 1998; 26(5):317-8. PubMed ID: 9795796
    [No Abstract]   [Full Text] [Related]  

  • 56. Seroprevalence of hepatitis A and B viruses in medical school students planning for medical clerkships.
    Lee J; Song H; Lee JM; Cho J
    Am J Infect Control; 2014 Jan; 42(1):89-90. PubMed ID: 24183533
    [No Abstract]   [Full Text] [Related]  

  • 57. Seroprevalence of hepatitis virus B seropositive in the patients with cholangiocarcinoma: a summary.
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2005; 6(1):27-8. PubMed ID: 15780027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prevalence of hepatitis B infection in adults with no recognized increased risk of infection.
    Soldan K; Gay NJ; Allain JP; Llewelyn C; Jones C; Reeves I; Ramsay M
    J Infect; 2000 Sep; 41(2):198-9. PubMed ID: 11023776
    [No Abstract]   [Full Text] [Related]  

  • 59. Isolated hepatitis B surface antibody as a sole marker for past HBV infection.
    Bisharat N; Segol O; Raz R; Flatau E
    J Infect; 1998 Sep; 37(2):201-2. PubMed ID: 9821104
    [No Abstract]   [Full Text] [Related]  

  • 60. [The prevalence of the serological markers of the hepatitis B virus in a nonhospital population].
    Masqué J; Cano P; Ripoll J; García RM
    Aten Primaria; 1993 Jun; 12(2):119-20. PubMed ID: 8329545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.